RecruitingNCT05925621
Cognitive Neurology Unit Clinical Registry
Cognitive Neurology Unit's Anti-amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease Clinical Registry
Sponsor
Beth Israel Deaconess Medical Center
Enrollment
500 participants
Start Date
Jul 16, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
A Prospective Comparative Study Of Monoclonal Antibodies For The Treatment Of Alzheimer's Disease
Eligibility
Min Age: 50 YearsMax Age: 95 Years
Plain Language Summary
Simplified for easier understanding
This is a clinical registry — a long-term data collection study — for people with mild cognitive impairment (MCI) or early Alzheimer's disease who are being evaluated and followed at a specialized memory clinic. The registry collects detailed clinical information over time to better understand how these conditions progress and to evaluate treatments.
**You may be eligible if:**
- You have mild cognitive impairment or early (not moderate or advanced) dementia from Alzheimer's disease, confirmed by cognitive testing
- You have a positive amyloid PET scan or abnormal spinal fluid results consistent with Alzheimer's disease
- You have had a brain MRI in the past 6 months
- You have a care partner (family member or friend who can provide support and information)
- You are a patient at the appropriate clinic (BI-Lahey amyloid clinic)
- You are on a stable medication regimen
**You may NOT be eligible if:**
- You have had a recent stroke or TIA (mini-stroke) in the past year
- You are pregnant
- You have an active autoimmune condition or are on immunosuppressant medications
- You have a bleeding disorder or are on blood thinners (warfarin, heparin, DOACs, or dual antiplatelet therapy)
- Your dementia is caused by something other than Alzheimer's disease
- You carry two copies of the ApoE e4 gene (a genetic risk factor for Alzheimer's)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGLecanemab
Observational study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05925621
Related Trials
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229255 locations
A Study of LY3439539 in Participants With Alzheimer's Disease
NCT075983707 locations
Olfactory Biopsies
NCT070210401 location
Sleep Trial to Prevent Alzheimer's Disease
NCT046295471 location
Music for Pain and Dementia
NCT076022831 location